Thinking Nasdaq listing has surely occurred to PH, and
may be reasons why he has not initiated this. Imugene
has involvement with US pharma now and it could be this involvement gives enough assurance of commercial-
isation at this point already. Not totally convinced that
share price would rise dramatically on Nasdaq, as other
stocks I have had previously have not fared well after listing.
Ben's comment that funds would be easier to raise after
listing could be true. Our Imugene team would be considering
all avenues to success I am convinced, and if dual listing
will get us a better chance, then I think it will occur.
But as always Ben, your writings are so very informative
and easy to understand, and invite new thinking.
Why IMU is a multi multi bagger, page-9073
-
- There are more pages in this discussion • 17,897 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
-0.004(7.55%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 4.9¢ | $1.061M | 21.17M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 6583733 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 1287081 | 5 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |